Labeler
U.S. Pharmaceuticals NDC Codes
U.S. Pharmaceuticals lists 22 finished drug products in the FDA NDC Directory under NDC labeler code 63539.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Talzenna, Cibinqo, Xeljanz, Ibrance, Xeljanz XR, Inlyta, Elrexfio, Litfulo, Zavzpret, Lorbrena, Duavee, Bosulif
- Active ingredients
- Tofacitinib citrate, Talazoparib tosylate, Abrocitinib, Palbociclib, Axitinib, Elranatamab, Ritlecitinib tosylate, Zavegepant hydrochloride, Lorlatinib, Estrogens, Conjugated, Bazedoxifene acetate, Bosutinib monohydrate
- NDC labeler codes
- 63539
- Strengths
- Talazoparib tosylate 1 mg/1; Talazoparib tosylate .5 mg/1; Elranatamab 44 mg/1.1mL; Ritlecitinib tosylate 50 mg/1; Zavegepant hydrochloride 10 mg/.1mL; Lorlatinib 25 mg/1; Abrocitinib 50 mg/1; Abrocitinib 100 mg/1; Abrocitinib 200 mg/1; Tofacitinib citrate 1 mg/mL; Palbociclib 75 mg/1; Palbociclib 100 mg/1; Palbociclib 125 mg/1; Tofacitinib citrate 22 mg/1; Tofacitinib citrate 10 mg/1; Tofacitinib citrate 11 mg/1; Estrogens, Conjugated .45 mg/1; Bazedoxifene acetate 20 mg/1; Tofacitinib citrate 5 mg/1; Bosutinib monohydrate 400 mg/1
- Dosage forms
- Tablet, Film coated, Capsule, Liquid filled, Capsule, Tablet, Extended release, Injection, Solution, Spray, Solution
- Routes
- Oral, Subcutaneous, Nasal
- Drug classes (FDA established)
- Kinase Inhibitor, Janus Kinase Inhibitor, Poly(ADP-Ribose) Polymerase Inhibitor, Calcitonin Gene-related Peptide Receptor Antagonist, Estrogen Agonist/Antagonist, Estrogen
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 22
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Talzennatalazoparib | Talazoparib tosylate .5 mg/1 | Capsule, Liquid filledOral | 63539-025 | 63539-0025-30 | — |
| Talzennatalazoparib | Talazoparib tosylate 1 mg/1 | Capsule, Liquid filledOral | 63539-031 | 63539-0031-30 | — |
| Elrexfioelranatamab-bcmm | Elranatamab 44 mg/1.1mL | Injection, SolutionSubcutaneous | 63539-252 | 63539-0252-02 | — |
| Litfuloritlecitinib | Ritlecitinib tosylate 50 mg/1 | CapsuleOral | 63539-334 | 63539-0334-28 | — |
| Zavzpretzavegepant | Zavegepant hydrochloride 10 mg/.1mL | SprayNasal | 63539-135 | 63539-0135-02 | — |
| Lorbrenalorlatinib | Lorlatinib 25 mg/1 | Tablet, Film coatedOral | 63539-927 | 63539-0927-01 | — |
| Cibinqoabrocitinib | Abrocitinib 50 mg/1 | Tablet, Film coatedOral | 63539-236 | 63539-0236-14 | — |
| Cibinqoabrocitinib | Abrocitinib 100 mg/1 | Tablet, Film coatedOral | 63539-336 | 63539-0336-14 | — |
| Cibinqoabrocitinib | Abrocitinib 200 mg/1 | Tablet, Film coatedOral | 63539-436 | 63539-0436-14 | — |
| Xeljanztofacitinib | Tofacitinib citrate 1 mg/mL | SolutionOral | 63539-029 | 63539-0029-02 | — |
| Ibrancepalbociclib | Palbociclib 75 mg/1 | Tablet, Film coatedOral | 63539-284 | 63539-0284-03 | — |
| Ibrancepalbociclib | Palbociclib 100 mg/1 | Tablet, Film coatedOral | 63539-486 | 63539-0486-03 | — |
| Ibrancepalbociclib | Palbociclib 125 mg/1 | Tablet, Film coatedOral | 63539-688 | 63539-0688-03 | — |
| Xeljanz XRtofacitinib | Tofacitinib citrate 22 mg/1 | Tablet, Extended releaseOral | 63539-502 | 63539-0502-30 | — |
| Talzennatalazoparib | Talazoparib tosylate 1 mg/1 | CapsuleOral | 63539-295 | 63539-0295-30 | — |
| Xeljanztofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | 63539-016 | 63539-0016-02 | — |
| Xeljanz XRtofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Extended releaseOral | 63539-501 | 63539-0501-30 | — |
| Duaveeconjugated estrogens/bazedoxifene | Estrogens, Conjugated .45 mg/1; Bazedoxifene acetate 20 mg/1 | Tablet, Film coatedOral | 63539-122 | 63539-0122-07 | — |
| Xeljanztofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | 63539-012 | 63539-0012-02 | — |
| Bosulifbosutinib | Bosutinib monohydrate 400 mg/1 | Tablet, Film coatedOral | 63539-193 | 63539-0193-30 | — |
| Inlytaaxitinib | Axitinib 1 mg/1 | Tablet, Film coatedOral | 63539-026 | 63539-0026-01 | — |
| Inlytaaxitinib | Axitinib 5 mg/1 | Tablet, Film coatedOral | 63539-044 | 63539-0044-02 | — |
U.S. Pharmaceuticals: common questions
- What is U.S. Pharmaceuticals's NDC labeler code?
- 63539. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for U.S. Pharmaceuticals?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.